Literature DB >> 12643937

Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.

Lei Zhao1, Mary K O'Reilly, Michael D Shultz, Jean Chmielewski.   

Abstract

Peptides derived from the interfacial region of dimeric HIV-1 integrase were evaluated as inhibitors of integrase's 3'-endonuclease activity. Three peptides were found to be moderately potent inhibitors with IC(50) values in the low micromolar range. The mode of inhibition was probed through protein crosslinking experiments. Active interfacial peptides were found to inhibit crosslinking of the dimeric form of integrase. Interfacial peptides that were poor inhibitors had no effect on integrase crosslinking.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643937     DOI: 10.1016/s0960-894x(03)00040-4

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

2.  New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.

Authors:  Manuel Tsiang; Gregg S Jones; Anita Niedziela-Majka; Elaine Kan; Eric B Lansdon; Wayne Huang; Magdeleine Hung; Dharmaraj Samuel; Nikolai Novikov; Yili Xu; Michael Mitchell; Hongyan Guo; Kerim Babaoglu; Xiaohong Liu; Romas Geleziunas; Roman Sakowicz
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

3.  Peptides derived from the HIV-1 integrase promote HIV-1 infection and multi-integration of viral cDNA in LEDGF/p75-knockdown cells.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Virol J       Date:  2010-08-02       Impact factor: 4.099

4.  Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry.

Authors:  Nick Shkriabai; Sachindra S Patil; Sonja Hess; Scott R Budihas; Robert Craigie; Terrence R Burke; Stuart F J Le Grice; Mamuka Kvaratskhelia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 5.  Piecing together the structure of retroviral integrase, an important target in AIDS therapy.

Authors:  Mariusz Jaskolski; Jerry N Alexandratos; Grzegorz Bujacz; Alexander Wlodawer
Journal:  FEBS J       Date:  2009-04-14       Impact factor: 5.542

6.  A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replication.

Authors:  Erik Serrao; Wannes Thys; Jonas Demeulemeester; Laith Q Al-Mawsawi; Frauke Christ; Zeger Debyser; Nouri Neamati
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

8.  Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.

Authors:  Hongtao Zhang; Francesca Curreli; Xihui Zhang; Shibani Bhattacharya; Abdul A Waheed; Alan Cooper; David Cowburn; Eric O Freed; Asim K Debnath
Journal:  Retrovirology       Date:  2011-05-03       Impact factor: 4.602

9.  Inhibiting the HIV integration process: past, present, and the future.

Authors:  Roberto Di Santo
Journal:  J Med Chem       Date:  2013-09-25       Impact factor: 7.446

Review 10.  Allosteric modulation of protein oligomerization: an emerging approach to drug design.

Authors:  Ronen Gabizon; Assaf Friedler
Journal:  Front Chem       Date:  2014-03-24       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.